This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (143)

Published on in Vol 5, No 4 (2016): Oct-Dec

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

Authors of this article:

Susan Creary1 Author Orcid Image ;   Deena J Chisolm2 Author Orcid Image ;   Sarah H O’Brien1 Author Orcid Image
Article Authors Cited by (9) Tweetations (4) Metrics

Journals

  1. Yahouédéhou S, da Guarda C, Figueiredo C, Santiago R, Carvalho S, Fiuza L, Ndidi U, Oliveira R, Carvalho M, Nascimento V, Rocha L, Lyra I, Adorno E, Goncalves M, Arez A. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia. PLOS ONE 2019;14(7):e0218040 View
  2. Reeves S, Jary H, Gondhi J, Raphael J, Lisabeth L, Dombkowski K. Hydroxyurea Initiation Among Children With Sickle Cell Anemia. Clinical Pediatrics 2019;58(13):1394 View
  3. Creary S, Chisolm D, Stanek J, Hankins J, O'Brien S. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study. JMIR mHealth and uHealth 2019;7(8):e13452 View
  4. Badawy S, Cronin R, Hankins J, Crosby L, DeBaun M, Thompson A, Shah N. Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review. Journal of Medical Internet Research 2018;20(7):e10940 View
  5. Ozdogu H, Boga C, Asma S, Kozanoglu I, Gereklioglu C, Yeral M, Buyukkurt N, Solmaz S, Korur A, Aytan P, Maytalman E, Kasar M. Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE). Medicine 2018;97(6):e9844 View
  6. Ingerski L, Loew M, Porter J, Su Y, Zhang H, Hankins J, Wang W. Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 2021;43(1):e19 View
  7. Shaner S, Hilliard L, Howard T, Pernell B, Bhatia S, Lebensburger J. Impact of telehealth visits on hydroxyurea response in sickle cell anemia. Pediatric Blood & Cancer 2021;68(12) View
  8. Yang M, Elmuti L, Badawy S, Demarin V. Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review. BioMed Research International 2022;2022:1 View
  9. Reeves S, Peng H, Wing J, Cogan L, Goel A, Anders D, Green N, Lisabeth L, Dombkowski K. Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines. JAMA Network Open 2023;6(3):e234584 View